Maybe a friend told you about their experience on Ozempic®. Maybe your doctor mentioned it. Maybe you’ve just been reading about it and wondering, "Could this be right for me?" Let’s walk through what the current guidance says and what you should consider before starting the conversation with your doctor.
The Official Criteria
GLP-1 medications (and newer drugs that also target the GIP receptor, like Mounjaro® and Zepbound®) are FDA-approved for specific conditions, and meeting the clinical criteria is generally the starting point for a prescription.
For weight management (Wegovy®, Zepbound®), current approvals are for adults with
A BMI of 30 or higher (classified as obesity) OR
A BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol
For type 2 diabetes (Ozempic®, Mounjaro®, others), these medications are approved for adults who need additional blood sugar control, often alongside other medications or lifestyle changes.
BMI Isn’t the Whole Story
It’s worth noting that BMI is an imperfect measure. It doesn’t account for muscle mass, bone density, or how fat is distributed in your body. Many doctors now consider additional factors, like waist circumference, metabolic health markers, and overall cardiovascular risk, when evaluating whether a GLP-1 medication makes sense for a given patient.
Who Should Be Cautious or Avoid These Medications?
GLP-1 medications aren’t appropriate for everyone. You should discuss carefully with your doctor if you have
A personal or family history of medullary thyroid cancer or a condition called MEN2 (multiple endocrine neoplasia type 2); this is a contraindication for some GLP-1 drugs
A history of pancreatitis
Kidney disease or impaired liver function
Pregnancy or plans to become pregnant (these medications are not recommended during pregnancy)
A history of eating disorders since the appetite-suppressing effects require careful monitoring in this context
What About People Who Don’t “Qualify” on Paper?
This is a gray area. Some people pursue GLP-1 medications through telehealth platforms or by paying out of pocket when their BMI doesn’t technically meet the threshold or their insurance won’t cover the cost. There’s a real debate in the medical community about where to draw the line, and guidelines may evolve as more research emerges.
If you’re in this category, the most important thing is to have an honest conversation with a qualified healthcare provider, not just to get a prescription but to make sure you understand the risks, benefits, and what to expect.
Beyond the Checklist: Are You Ready?
Clinical criteria aside, there are some practical and personal factors worth thinking about:
These medications work best alongside lifestyle changes, like nutrition, exercise, and behavior support
They require consistent use; stopping often leads to weight regain
Side effects, especially early on, can be significant for some people
Cost and insurance coverage vary widely and can be a real barrier
BMI matters, but so does being informed, prepared, and supported.
Where to Start?
If you’re curious about GLP-1 therapy, start with your primary care doctor or an obesity medicine specialist. Bring your questions, be honest about your history, and don’t be discouraged if it takes a few conversations to find the right path forward. These medications have helped millions of people make meaningful progress toward their health goals, but the right fit matters.
The FDA-approved GLP-1 receptor agonist medications discussed in this article are prescription medications for specific indications: semaglutide (Ozempic®) for type 2 diabetes and to reduce cardiovascular risk in adults with type 2 diabetes and cardiovascular disease; semaglutide (Wegovy®) for chronic weight management; tirzepatide (Mounjaro®) for type 2 diabetes; and tirzepatide (Zepbound®) for chronic weight management. This article is for educational and informational purposes only and does not constitute medical advice. Individual results may vary. Consult your healthcare provider to determine if GLP-1 therapy is appropriate for your individual health situation and to discuss potential risks, side effects, and contraindications.
Leave a Comment
Your email address will not be published. Required fields are marked *